Medtech companies directory 2026

    Medical Device Companies in Singapore

    Singapore is a city-state hospital market and a Southeast Asian device hub in the same postcode: HSA Class A–D registration is the legal door, the three public clusters plus IHH/Parkway are the buyers, and a Jurong or Tuas warehouse is often the stock point for brands that will never employ a full Malaysian or Indonesian field force.

    The Health Sciences Authority licences devices and dealers. Esco is the local life-science and hospital-equipment manufacturer that export decks already know. Biosensors International is the Singapore-born interventional house now inside a larger group. Becton Dickinson runs a regional hub from the island; Siemens Healthineers’ SEA organisation sits here and covers accounts the cluster CMOs actually name. Parkway and the wider IHH system are the private buyer; NUHS and National University Hospital are the public academic door; SingHealth and NHG complete the cluster map. BioNixus fields those named cluster and Parkway desks, not a “ASEAN hospital” blend.

    Updated September 2026 · HSA — Health Sciences Authority, medical device and dealer licensing as of September 2026 · 16 named accounts

    HSA

    Health Sciences Authority — Class A–D device and dealer licensing

    3 clusters

    SingHealth, NHG and NUHS — public buying systems that do not share one catalogue

    IHH / Parkway

    Private-hospital door that buys on a different clock from the clusters

    SEA hub

    Jurong and Tuas warehouses that feed brands into Malaysia, Indonesia and beyond

    Named accounts

    Top medical device companies in Singapore

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against HSA — Health Sciences Authority, medical device and dealer licensing (as of 2026-09-05).
    #CompanyHQ
    01HSA (Health Sciences Authority)Singapore
    02NUHS / National University Hospital procurementSingapore
    03SingHealth group procurementSingapore
    04EscoSingapore
    05Biosensors InternationalSingapore
    06Becton Dickinson Singapore hubSingapore
    07Siemens Healthineers SEASingapore
    08Parkway / IHH Singapore hospitalsSingapore
    09National Healthcare Group (NHG) procurementSingapore
    10Transmedic / specialist Singapore dealersSingapore
    11DKSH medical SingaporeSingapore
    12Medtronic SingaporeSingapore
    13GE HealthCare SingaporeSingapore
    14Olympus SingaporeSingapore
    15MOH cluster capital overlaySingapore
    16National University Hospital (as named account)Singapore

    Primary research

    These are the medical device companies accounts we study in Singapore

    Need account-level or SKU-level data for a brand in Singapore? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in Singapore?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in Singapore (2026)

    How the market is structured

    HSA class, cluster catalogue, Parkway desk

    A device that will be used in a Singapore public ward needs an HSA registration in the right class, a licensed dealer, and a place on a cluster catalogue or a hospital-level evaluation that the cluster CMO and the biomedical-engineering department will defend. Class A is the lightest file; Class D is the implant and high-risk path. That file is not the sale. SingHealth, the National Healthcare Group and NUHS buy as three systems: a National University Hospital evaluation does not automatically stock a SingHealth institution, and NHG’s Tan Tock Seng has its own capital committee. Capital equipment — imaging, OR integration, ICU ventilation — is specified by the user department and purchased against cluster capital envelopes that MOH still shadows. Private Parkway hospitals (Gleneagles, Mount Elizabeth, Parkway East) and the wider IHH book buy on a faster capital cycle and will take a premium SKU the cluster has not yet catalogued. Consumables ride dealer licences: BD’s Singapore hub, local dealers such as Transmedic and DKSH’s device book, and manufacturer subsidiaries that hold both the HSA dealer licence and the cluster vendor code. Esco sells laboratory and some hospital equipment from a Singapore manufacturing base into the clusters and into export. Biosensors’ interventional products still appear in regional cath-lab conversations even as the corporate parent has shifted. Siemens Healthineers SEA uses the island as a commercial and service hub; the cluster still invoices a Singapore entity. BioNixus reconstructs the named HSA class, the named cluster catalogue and the named Parkway desk before a Singapore number is treated as a regional proxy.

    Local

    Esco and Biosensors — Singapore-origin houses whose factories or origin stories already sit in cluster and regional cath-lab conversations.

    • Esco
    • Biosensors International

    Multinational

    BD, Siemens SEA, Medtronic, GE and Olympus seats that use the island as a cluster-facing and SEA-hub organisation.

    • Becton Dickinson Singapore hub
    • Siemens Healthineers SEA
    • Medtronic Singapore
    • GE HealthCare Singapore
    • Olympus Singapore

    Regional

    Licensed dealers (Transmedic, DKSH and peers) that hold HSA dealer licences and cluster vendor codes for brands without a full field force.

    Distributors & service partners

    HSA as the class-and-dealer gate, three public clusters plus MOH envelopes, Parkway/IHH as the private door.

    • HSA (Health Sciences Authority)
    • NUHS / National University Hospital procurement
    • SingHealth group procurement
    • Parkway / IHH Singapore hospitals
    • National Healthcare Group (NHG) procurement
    • Transmedic / specialist Singapore dealers
    • DKSH medical Singapore
    • MOH cluster capital overlay
    • National University Hospital (as named account)

    What is moving

    What is moving the medical device market in Singapore

    Cluster catalogue fragmentation

    SingHealth, NHG and NUHS do not share one list. A NUH evaluation that never reached SGH is a failed public launch, not a soft start.

    Parkway capital speed versus cluster envelopes

    IHH hospitals will take a premium SKU months before a cluster envelope opens; BioNixus splits those two clocks in every Singapore forecast.

    SEA hub inventory versus island demand

    Jurong and Tuas warehouses serve Malaysia and Indonesia as much as they serve NUH. Counting hub stock as Singapore hospital demand overstates the island.

    HSA class upgrades and dealer-licence hygiene

    Cluster biomedical engineers now ask for class and dealer numbers on the evaluation form; a regional HQ slide is not a substitute.

    BioNixus fieldwork

    How BioNixus studies medical device companies in Singapore

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Singapore:
    • SingHealth, NHG and NUHS catalogue walks treated as three public doors, never as one MOH buyer.
    • HSA class-and-dealer number checks against the carton a cluster CSSD actually accepts.
    • Parkway / IHH capital-desk interviews timed against cluster envelope calendars.
    • Jurong and Tuas hub-stock splits so SEA warehouse volume is not counted as island hospital demand.

    Healthcare market research in Singapore

    Questions

    Frequently Asked Questions

    How are medical devices registered in Singapore?

    HSA classes them A to D and licences the dealer. The cluster biomedical engineer will ask for both numbers before the SKU joins an evaluation shortlist.

    Who buys devices for public hospitals?

    Three clusters — SingHealth, NHG and NUHS — plus a MOH shadow on capital envelopes. National University Hospital is a NUHS account, not the national buyer.

    How does Parkway / IHH buy compared with the clusters?

    Faster capital cycles, thinner catalogue discipline, more willingness to take a premium SKU the public list has not opened. It is a different commercial object.

    Which Singapore-origin device names belong on a brief?

    Esco for laboratory and hospital-adjacent equipment, Biosensors International for the interventional origin story, plus the island hubs of BD and Siemens SEA.

    What does BioNixus study on Singapore device accounts?

    HSA class-and-dealer traces, named cluster-catalogue reconstructions, Parkway desk interviews, and hub-versus-island inventory splits.

    Is this a ranking of Singapore medtech share?

    No. Names appear because they recur in BioNixus cluster and Parkway fieldwork; sequence is by role, not by revenue.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Singapore. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: HSA — Health Sciences Authority, medical device and dealer licensing, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in Singapore, not size.

    • HSA medical-device classification and dealer-licence guidance, consulted 2026
    • MOH cluster and institution procurement notices; NUHS and NUH published descriptions
    • Esco, Biosensors, BD and Siemens Healthineers published Singapore / SEA site descriptions
    • BioNixus Singapore cluster and Parkway hospital fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in Singapore?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in Singapore?

    Primary research, market access & HEOR. Proposals within 48 hours.